{"nct_id":"NCT05704725","title":"A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD)","status":"COMPLETED","status_verified_date":"2025-02","start_date":"2023-01-23","start_date_type":"ACTUAL","primary_completion_date":"2023-02-17","primary_completion_date_type":"ACTUAL","completion_date":"2023-03-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}